Cargando…
Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
[Image: see text] N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei. We report the optimization of a high throughput screening hit (1) to give a lead molecule DDD85646 (63), which has...
Autores principales: | Brand, Stephen, Cleghorn, Laura A. T., McElroy, Stuart P., Robinson, David A., Smith, Victoria C., Hallyburton, Irene, Harrison, Justin R., Norcross, Neil R., Spinks, Daniel, Bayliss, Tracy, Norval, Suzanne, Stojanovski, Laste, Torrie, Leah S., Frearson, Julie A., Brenk, Ruth, Fairlamb, Alan H., Ferguson, Michael A. J., Read, Kevin D., Wyatt, Paul G., Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2011
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256935/ https://www.ncbi.nlm.nih.gov/pubmed/22148754 http://dx.doi.org/10.1021/jm201091t |
Ejemplares similares
-
Design and Synthesis
of Brain Penetrant Trypanocidal N-Myristoyltransferase
Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017) -
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015) -
Lead Optimization of a Pyrazole
Sulfonamide Series
of Trypanosoma bruceiN-Myristoyltransferase Inhibitors: Identification and Evaluation
of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human
African Trypanosomiasis
por: Brand, Stephen, et al.
Publicado: (2014) -
N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010) -
A Molecular Hybridization
Approach for the Design
of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
por: Harrison, Justin R., et al.
Publicado: (2018)